WallStreetZenWallStreetZen

NASDAQ: BCYC
Bicycle Therapeutics PLC Stock Forecast, Predictions & Price Target

Analyst price target for BCYC

Based on 7 analysts offering 12 month price targets for Bicycle Therapeutics PLC.
Min Forecast
$32.00+29.87%
Avg Forecast
$46.86+90.17%
Max Forecast
$65.00+163.8%

Should I buy or sell BCYC stock?

Based on 7 analysts offering ratings for Bicycle Therapeutics PLC.
Strong Buy
Strong Buy
3 analysts 42.86%
Buy
3 analysts 42.86%
Hold
1 analysts 14.29%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their BCYC stock forecasts and price targets.

BCYC stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-02-21
lockedlocked$00.00+00.00%2024-02-21
lockedlocked$00.00+00.00%2024-02-21
lockedlocked$00.00+00.00%2023-12-20
lockedlocked$00.00+00.00%2023-11-08
Morgan Stanley
Top 11%
90
HoldMaintains$40.00+62.34%2023-11-03
B. Riley Securities
Top 17%
84
Strong BuyUpgrades$33.00+33.93%2023-09-12

1 of 1

Forecast return on equity

Is BCYC forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.62%

Forecast return on assets

Is BCYC forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

BCYC revenue forecast

What is BCYC's revenue in the next 3 years based on estimates from 6 analysts?
Avg 1 year Forecast
$33.2M+23.2%
Avg 2 year Forecast
$32.8M+21.43%
Avg 3 year Forecast
$42.5M+57.48%
BCYC's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

BCYC revenue growth forecast

How is BCYC forecast to perform vs Biotechnology companies and vs the US market?
Company
14.15%
Industry
52.23%
Market
10%
BCYC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
BCYC's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

BCYC vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
BCYC$24.64$46.86+90.17%Strong Buy
TARS$31.70$39.33+24.08%Buy
RNA$14.04$42.50+202.71%Strong Buy
AUTL$6.11$9.50+55.48%Strong Buy
IMTX$12.22N/AN/A

Bicycle Therapeutics Stock Forecast FAQ

Is Bicycle Therapeutics Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 7 Wall Street analysts covering (NASDAQ: BCYC) stock is to Strong Buy BCYC stock.

Out of 7 analysts, 3 (42.86%) are recommending BCYC as a Strong Buy, 3 (42.86%) are recommending BCYC as a Buy, 1 (14.29%) are recommending BCYC as a Hold, 0 (0%) are recommending BCYC as a Sell, and 0 (0%) are recommending BCYC as a Strong Sell.

If you're new to stock investing, here's how to buy Bicycle Therapeutics stock.

What is BCYC's revenue growth forecast for 2024-2026?

(NASDAQ: BCYC) Bicycle Therapeutics's forecast annual revenue growth rate of 14.15% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 52.23%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10%.

Bicycle Therapeutics's revenue in 2024 is $26,976,000.On average, 6 Wall Street analysts forecast BCYC's revenue for 2024 to be $1,415,351,858, with the lowest BCYC revenue forecast at $851,723,700, and the highest BCYC revenue forecast at $2,274,102,279. On average, 6 Wall Street analysts forecast BCYC's revenue for 2025 to be $1,395,038,248, with the lowest BCYC revenue forecast at $851,723,700, and the highest BCYC revenue forecast at $2,342,240,175.

In 2026, BCYC is forecast to generate $1,809,146,311 in revenue, with the lowest revenue forecast at $907,937,464 and the highest revenue forecast at $2,555,171,100.

What is BCYC's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: BCYC) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is BCYC's Price Target?

According to 7 Wall Street analysts that have issued a 1 year BCYC price target, the average BCYC price target is $46.86, with the highest BCYC stock price forecast at $65.00 and the lowest BCYC stock price forecast at $32.00.

On average, Wall Street analysts predict that Bicycle Therapeutics's share price could reach $46.86 by Feb 21, 2025. The average Bicycle Therapeutics stock price prediction forecasts a potential upside of 90.17% from the current BCYC share price of $24.64.

What is BCYC's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: BCYC) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.